ANTH
ANTHERA PHARMS INC NEW
stockOTC

Latest News

Nov 13, 2026

04:50 AM ESTAnthropic's IPO Valuation Sparks Investor Interest Amid AI Sector Uncertainty · GuruFocus

Nov 12, 2026

12:41 PM ESTBond king Jeffrey Gundlach on buying Anthropic debt: 'Makes me want to break out in hives' · Yahoo Finance

06:10 AM ESTDubai Tycoon Predicts Billions from AI Investments in Anthropic · GuruFocus

Nov 11, 2026

05:53 AM ESTAnthropic Faces Risks Ahead of IPO Amid Market Sentiment Shifts · GuruFocus

Nov 10, 2026

11:30 AM ESTAnthropic's IPO Valuation Could Reach $1.4 Trillion Amid Revenue Surge · GuruFocus

anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: anth